Biopharmas raising money in public or private financings, including: Acceleron, Akari, Akouos, Amylyx, Chiasma, Crispr Therapeutics, DFP Healthcare Acquisitions, IMV, Orphazyme, Painreform, Panacea Acquisition, Tela Bio.
Already a subscriber? Sign in